Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study
- PMID: 11358770
- PMCID: PMC31616
- DOI: 10.1136/bmj.322.7296.1203
Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study
Abstract
Objective: To evaluate the effects on suicidal behaviour of legislation limiting the size of packs of paracetamol and salicylates sold over the counter.
Design: Before and after study.
Setting: UK population, with detailed monitoring of data from five liver units and seven general hospitals, between September 1996 and September 1999.
Subjects: People who died by suicidal or accidental overdose with paracetamol or salicylates or who died of undetermined causes; patients admitted to liver units with hepatic paracetamol poisoning; patients presenting to general hospitals with self poisoning after taking paracetamol or salicylates.
Main outcome measures: Mortality from paracetamol or salicylate overdose; numbers of patients referred to liver units or listed for liver transplant; numbers of transplantations; numbers of overdoses and tablets taken; blood concentrations of the drugs; prothrombin times; sales to pharmacies and other outlets of paracetamol and salicylates.
Results: Numbers of tablets per pack of paracetamol and salicylates decreased markedly in the year after the change in legislation on 16 September 1998. The annual number of deaths from paracetamol poisoning decreased by 21% (95% confidence interval 5% to 34%) and the number from salicylates decreased by 48% (11% to 70%). Liver transplant rates after paracetamol poisoning decreased by 66% (55% to 74%). The rate of non-fatal self poisoning with paracetamol in any form decreased by 11% (5% to 16%), mainly because of a 15% (8% to 21%) reduction in overdoses of paracetamol in non-compound form. The average number of tablets taken in paracetamol overdoses decreased by 7% (0% to 12%), and the proportion involving >32 tablets decreased by 17% (4% to 28%). The average number of tablets taken in salicylate overdoses did not decrease, but 34% fewer (2% to 56%) salicylate overdoses involved >32 tablets. After the legislation mean blood concentrations of salicylates after overdose decreased, as did prothrombin times; mean blood concentrations of paracetamol did not change.
Conclusion: Legislation restricting pack sizes of paracetamol and salicylates in the United Kingdom has had substantial beneficial effects on mortality and morbidity associated with self poisoning using these drugs.
Figures



Comment in
-
Effects of legislation restricting pack sizes of paracetamol on self poisoning. Authors did not look at effects on all deliberate and accidental self poisoning.BMJ. 2001 Sep 15;323(7313):633-4. BMJ. 2001. PMID: 11575320 No abstract available.
-
Effects of legislation restricting pack sizes of paracetamol on self poisoning. Paracetamol should be packaged with its antidote.BMJ. 2001 Sep 15;323(7313):634. BMJ. 2001. PMID: 11575321 No abstract available.
Similar articles
-
Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature.Drug Saf. 2007;30(6):465-79. doi: 10.2165/00002018-200730060-00002. Drug Saf. 2007. PMID: 17536874 Review.
-
UK legislation on analgesic packs: before and after study of long term effect on poisonings.BMJ. 2004 Nov 6;329(7474):1076. doi: 10.1136/bmj.38253.572581.7C. Epub 2004 Oct 29. BMJ. 2004. PMID: 15516343 Free PMC article.
-
Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses.BMJ. 2013 Feb 7;346:f403. doi: 10.1136/bmj.f403. BMJ. 2013. PMID: 23393081 Free PMC article.
-
Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland.Br J Clin Pharmacol. 2006 Nov;62(5):573-81. doi: 10.1111/j.1365-2125.2006.02668.x. Br J Clin Pharmacol. 2006. PMID: 17061964 Free PMC article.
-
Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse.Suicide Life Threat Behav. 2000 Winter;30(4):313-26. Suicide Life Threat Behav. 2000. PMID: 11210057 Review.
Cited by
-
Ease of access is a principal factor in the frequency of paracetamol overdose.Ir J Med Sci. 2002 Jul-Sep;171(3):148-50. doi: 10.1007/BF03170503. Ir J Med Sci. 2002. PMID: 15736354
-
Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings.BMJ. 2003 May 10;326(7397):1006-8. doi: 10.1136/bmj.326.7397.1006. BMJ. 2003. PMID: 12742920 Free PMC article.
-
Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed?Postgrad Med J. 2006 Aug;82(970):520-3. doi: 10.1136/pgmj.2005.042036. Postgrad Med J. 2006. PMID: 16891443 Free PMC article.
-
Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database.Eur J Pediatr. 2019 Feb;178(2):161-172. doi: 10.1007/s00431-018-3281-0. Epub 2018 Oct 29. Eur J Pediatr. 2019. PMID: 30374752
-
Assessing suicide risk among callers to crisis hotlines: a confirmatory factor analysis.J Clin Psychol. 2010 Sep;66(9):941-64. doi: 10.1002/jclp.20717. J Clin Psychol. 2010. PMID: 20578186 Free PMC article.
References
-
- Hawton K, Fagg J, Simkin S, Bale E, Bond A. Trends in deliberate self-harm in Oxford, 1985-1995. Implications for clinical services and the prevention of suicide. Br J Psychiatry. 1997;171:556–560. - PubMed
-
- Bialas MC, Reid PG, Beck P, Lazarus JH, Smith P M, Scorer RC. Changing patterns of self-poisoning in a UK health district. Q J Med. 1996;89:893–901. - PubMed
-
- Spooner JB, Harvey JG. Paracetamol overdoses—facts not misconceptions. Pharm J. 1993;May 22:706–707.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical